Isotretinoin 30 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV423
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,620
Award facts
- Contract value 100% obligated
- $2,619.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, demonstrates significant capability in fulfilling federal medical procurement requirements across multiple therapeutic domains. The company's portfolio includes specialty medications, brand-name and generic drugs, vaccines, and medical devices supplied to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Isotretinoin, a medication used in dermatological treatment, reflects the company's continued role as a critical vendor in the military medical supply chain and represents a routine fulfillment under its comprehensive pharmaceutical prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26FV423?
SPE2DR26FV423 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV423 worth?
The government has obligated $2,620 on SPE2DR26FV423.
Is contract SPE2DR26FV423 an order under another contract?
Yes. SPE2DR26FV423 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV423 competed?
The extent of competition for SPE2DR26FV423 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award